Award recordCONTRACT

CAREMARK RX, L.L.C.

PIID 36C26123P0590· VHA· 261-NETWORK CONTRACT OFFICE 21 (36C261)· 6505 · DRUGS AND BIOLOGICALS· FY2023· $0 net obligations· UEI EP32BZ8XN3A2· IL

Description

EMERGENCY TYVASO

First action · last action
2023-01-26 · 2023-01-30
Transactions
2
First transaction's obligation
$85,328
Base + all options value (sum of deltas)
$85,328
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$85,328$0Base award · 2023-01-26 · this action $85,328 · running total $85,328Modification P00001 · 2023-01-30 · this action -$85,328 · running total $0
  • Base2023-01-26+$85,328= $85,328
  • Mod P000012023-01-30-$85,328= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2023-01-26+$85,328$85,328EMERGENCY TYVASO
Mod P00001· OTHER ADMINISTRATIVE ACTION2023-01-30−$85,328$0EMERGENCY TYVASO

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI EP32BZ8XN3A2)

AwardOffice · PSC / listingNet obligationsFY
36C26123P0628261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$14,221FY2023
36C26123P0479261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$13,557FY2023
36C26123P0366261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$13,557FY2023
36C26123P0086261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$13,557FY2023
36C26122P1803261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$13,557FY2022
36C26122P1626261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$13,557FY2022

Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26126P1178OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026
36C26126P1102ENVIGO RMS LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$74,586FY2026
36C26126P096110X GENOMICS, INC.261-NETWORK CONTRACT OFFICE 21 (36C261)$34,600FY2026
36C26126P0997SIERRA RADIOPHARMACY LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$247,204FY2026
36C26126P1008OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26123P0590_3600_-NONE-_-NONE- · retrieved 2026-09-26.